AAV vector-mediated muscle directed gene therapy results in long-term enzymatic and functional correction in cardio-vascular system of Fabry mouse

被引:0
|
作者
Takahashi, H
Seino, Y
Fukumoto, H
Hirai, Y
Shimada, T
Takano, T
机构
[1] Nippon Med Coll, Dept Internal Med 1, Tokyo 113, Japan
[2] Nippon Med Coll, Dept Biochem & Mol Biol, Tokyo 113, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
138
引用
收藏
页码:28 / 28
页数:1
相关论文
共 44 条
  • [1] Adeno-associated viral vector-mediated gene transfer results in long-term enzymatic and functional correction in multiple organs of Fabry mice
    Jung, SC
    Han, IP
    Limaye, A
    Xu, R
    Gelderman, MP
    Zerfas, P
    Tirumalai, K
    Murray, GJ
    During, MJ
    Brady, RO
    Qasba, P
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (05) : 2676 - 2681
  • [2] Long-Term Enzymatic and Phenotypic Correction in the Phenylketonuria Mouse Model by Adeno-Associated Virus Vector-Mediated Gene Transfer
    Hyun-Jeong Oh
    Eun-Sook Park
    Seongman Kang
    Inho Jo
    Sung-Chul Jung
    Pediatric Research, 2004, 56 : 278 - 284
  • [3] Long-term enzymatic and phenotypic correction in the phenylketonuria mouse model by adeno-associated virus vector-mediated gene transfer
    Oh, HJ
    Park, ES
    Kang, SM
    Jo, I
    Jung, SC
    PEDIATRIC RESEARCH, 2004, 56 (02) : 278 - 284
  • [4] Long-term systemic therapy of Fabry disease in a knockout mouse by adeno-associated virus-mediated muscle-directed gene transfer
    Takahashi, H
    Hirai, Y
    Migita, M
    Seino, Y
    Fukuda, Y
    Sakuraba, H
    Kase, R
    Kobayashi, T
    Hashimoto, Y
    Shimada, T
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (21) : 13777 - 13782
  • [5] Complete correction of hyperphenylalaninemia following liver-directed, recombinant AAV2/8 vector-mediated gene therapy in murine phenylketonuria
    Harding, CO
    Gillingham, MB
    Hamman, K
    Clark, H
    Goebel-Daghighi, E
    Bird, A
    Koeberl, DD
    GENE THERAPY, 2006, 13 (05) : 457 - 462
  • [6] Pigtailed macaques as a model to study long-term safety of lentivirus vector-mediated gene therapy for hemoglobinopathies
    Kiem, Hans-Peter
    Arumugam, Paritha I.
    Burtner, Christopher R.
    Fox, Catherine F.
    Beard, Brian C.
    Dexheimer, Phillip
    Adair, Jennifer E.
    Malik, Punam
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2014, 1 : 14055
  • [7] Complete correction of hyperphenylalaninemia following liver-directed, recombinant AAV2/8 vector-mediated gene therapy in murine phenylketonuria
    C O Harding
    M B Gillingham
    K Hamman
    H Clark
    E Goebel-Daghighi
    A Bird
    D D Koeberl
    Gene Therapy, 2006, 13 : 457 - 462
  • [8] A Long-Term Study of AAV Vector-Mediated Gene Therapy for X-linked Retinitis Pigmentosa (XLRP) Due to RP2 Mutation
    Mookherjee, Suddhasil
    Colosi, Peter
    Hiriyanna, Suja
    Kaneshiro, Kayleigh
    Li, Linjing
    Qian, Haohua
    Li, Tiansen
    Khanna, Hemant
    Swaroop, Anand
    Wu, Zhijian
    MOLECULAR THERAPY, 2014, 22 : S46 - S46
  • [9] Long-term follow-up of liver-directed, adeno-associated, vector-mediated gene therapy in the canine model of hemophilia A
    Lillicrap, D.
    Harpell, L.
    Labelle, A.
    Webster, S.
    HAEMOPHILIA, 2012, 18 : 65 - 65
  • [10] Long-term follow-up of liver-directed, adeno-associated vector-mediated gene therapy in the canine model of hemophilia A
    Batty, P.
    Mo, A. M.
    Hurlbut, D.
    Ishida, J.
    Yates, B.
    Brown, C.
    Harpell, L.
    Hough, C.
    Pender, A.
    Rimmer, E. K.
    Infirri, S. Sardo
    Winterborn, A.
    Fong, S.
    Lillicrap, D.
    BLOOD, 2022, 140 (25) : 2672 - 2683